Apologies in advance for the long post... click Next if you

New Post Public Reply Private Reply Replies (2) Message Board
Warp Daveludlow #6219
Apologies in advance for the long post... click Next if you don't want to waste the next 2 minutes of your life. LOL

Dave, the dilution concern you continue to refer to as legitimate is obviously not shared by the majority on this board. We are not the naive investors as you think we are. But your concerns over this issue are starting to sound like the rants of those who believe the moon landings were faked, and are frustrated they can't convince everyone else of the truth of this. Seriously, you need to get a grip. Take your concerns to the company, or sell your shares. Most of the naive investors here understand the dilution concern yet we choose to remain invested and keep our focus on the company and the bright outlook of our future.

So your 1.1 million shares represent hard earned money, do they? What the hell do my shares represent? You have no f*cking idea what you're talking about when you make any attempt to characterize me or my investment style. I take my concerns to the source, not to a public message board where others can do little to nothing about it. Gerald has personally addressed every one of my concerns, and in some cases stated the company would be addressing those concerns in the near future, which they have. I'm satisfied with that. If that's a passive investor, then I suppose I choose to remain a passive investor vs. claiming to be a LT investor yet fretting and losing sleep over every possible outcome in my investment. I feel management has enough challenges ahead of them without me creating more by constantly reminding them of my own insecurities with my investment decision. As Gerald has stated, they are building a world-class biotech company, and if I can't stand the heat of the kitchen, then I should sell my shares and move on. Good advice, in my opinion.

It is not the CEO's job to manage my investment as you claim. It is management's job to manage the company and bring shareholder value, using their knowledge and experience to manage the science and build the best shareholder value they can based on bringing their assets to market. It is my job to manage my investment. It is my job to decide to stick with this investment or not based on my results and how I view the company being managed. It is not my job to try to manage the company, nor attempt to sway investor sentiment to agree with my opinion and put pressure on management to better manage my investment. They are busy running the company. If I had the qualifications to manage the company, I'd be working for them, not simply buying their shares.

You seem to believe I'm wealthy. Again, your analysis here sucks. What is your definition of wealth? And how do you think I came into the money to buy my large position? I'll tell you how. I worked my ass off for years, working 12-hour rotating shifts, and adding 600+ hours annually of overtime for many years. While others were taking off to spend time with family and friends on weekends and holidays, I was at the nuclear plant working. So I would characterize my investment dollars just as hard earned, if not more so, than those you've put into your investment. So how about less talk of your hard-earned dollars? Most here earned the money they invest. Your dollars are no different than anyone else's here.

I can assure you of this... if I only owned 100K or 500K in AMBS shares, my concern over possible dilution ahead would be no different than it is now. I live in reality, not the fantasy world you suggest. The real world would have investors who wouldn't invest in pre-revenue biotech companies if they were concerned about dilution. In the fantasy world, investors invest in such companies often to counter their life-long tendency to borrow for everything, not save enough for retirement, and pin all of their hopes on striking it rich, which is why they fret over everything that "might" happen with their investment, instead of having more trust in management to do what is best both for shareholders and the company.

Let me tell you how I view God in this environment. I pray for Gerald and his team, and those conducting the research to help those in need. I pray that this investment will work out the way God intends, whatever that may be. And I pray God has my best interests in mind, whether that is to provide me with abundant wealth to help others in need, or to teach me a valuable lesson about what many would consider my foolish investment of my limited resources in a risky company like Amarantus.

So, while you are fretting and flipping out over what might happen, I have faith this will all work out as God intended. Gerald is not God. But I believe he is genuinely a good person and may very well be one of God's instruments to help those suffering from these various afflictions. And if I'm blessed to enjoy some rewards as a shareholder, I will certainly do my part in passing on some of those blessings to others in need, as well as my local church to spread God's ministry. If you think that's a "passive" investor, so be it. I imagine my blood pressure and sleep patterns are a lot better than yours. And my faith this will all work according to God's plan gives me comfort. That doesn't mean I don't bring my concerns to the company. One would be a fool to blindly invest and hope it all works out, but we obviously have different levels of faith in this investment.

I'd rather drink Kool-Aid than whatever brew you're drinking. What I'm drinking isn't causing unnecessary concerns over what might happen down the road. You really should watch a specific episode of Deep Space Nine called "Statistical Probabilities" (season 6, episode 9). It is a prime example of your over-analysis of everything Amarantus, and how a single event can change everything and make all of the analysis moot.

Speaking of maturity, it seems to me most here are calm adults who understand the risks. But some seem to be spoiled brats crying for attention and pissed off that everyone else doesn't share their concerns.

One final point... you should work on your reading skills because your mention of my post regarding one of the callers on the recent business update call is way off.

What you posted:
Quote:
Unlike Warp, I thought the gentleman who pressed Gerald on those 5 questions during the CC was right on!! Warp writes off discussion about concerns as anxious "hand wringing" and the cause of "sleepless nights" that only the poor engage in, who really shouldn't be invested in this type of stock in the first place. I thought the gentleman asking the questions on the CC was respectful, but earnest.
What I posted:
Quote:
I sat here listening to these 5 questions and was scratching my head, particularly the ones asking Gerald to reveal any partnerships or asset sales in the works, and when the company expected to be profitable. It's sad this investor took up so much time on the call where other investors could have asked reasonable questions that Gerald might be able to legally answer.

So you believe a reasonable investor question would be for specifics on upcoming sales of the LymPro and Eltoprazine assets, or when the company will reach profitability based on partnership agreements or asset sales currently in the works? You really see those questions as respectful and ernest? What fantasy world are you living in? There's no way Gerald could answer those questions, and not wind up with SEC fines or removal by the BOD as CEO. Respectful and ernest? What kind of shareholder would even ask those questions? One who is out of his league as an investor here and should stick with investing in mutual funds. I'm surprised you feel these were valid questions that should be asked.

Amarantus Bioscience Holdings (AMBS) Stock Research Links

AMBS Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

College Towns Spark Entrepreneurial Booms Across US

Updated Category News Views 66

Entrepreneurial Sparks Fly in Unlikely Places Turns out, it's not just the Silicon Valleys of the world creating startups—sometimes it's the coffee-driven college town where innovation quietly roots itself. GoDaddy's inaugural list of America's Most Entrepreneurial College Towns decimates the old idea that only big cities can be entrepreneurial havens. Instead, eight...

Continue Reading
ChinaMarket: Linyi's Gateway for Global Buying Delegations

Updated Category News Views 64

Unlocking Trade Potential in Linyi, China Linyi, in Shandong province, has flipped the switch on the sourcing circuit with one powerful invite to global buying delegations. As we sit perched on the fence of an economically tangled world, China's open arms to Southeast and Central Asian buyers mark a significant shift towards more fluid trade connections. The Fourth Linyi...

Continue Reading
Tradier Brokerage Data Breach Sparks Legal Probe

Updated Category News Views 27

Data Breach Drama Hits Tradier Brokerage Picture a broker-dealer like Tradier Brokerage, out in Charlotte, getting its customers' details hanging out there for the world to see. A calamity, courtesy of a cyberattack on their third-party vendor, Etna Software Corp. And we're talking Social Security numbers, tax IDs—emails across Texas and Massachusetts were popping up...

Continue Reading
The Sift: Slickdeals’ Game-Changing Black Friday Tool

Updated Category News Views 259

Revolutionizing Black Friday Planning Off we go, diving headfirst into the chaotic whirlpool that is Black Friday shopping. Slickdeals seems to think they’ve got the golden ticket with The Sift, and I can't say they're wrong. Instead of the traditional paper ad scans we've been sifting through since the dawn of time, The Sift brings all announced deals into one...

Continue Reading
MacGregor Revamps Fleet for Wallenius Wilhelmsen Deal

Updated Category News Views 90

MacGregor's Big Move: Retrofitting 35 Vessels I'll tell you something right off the bat—the maritime industry's always got some sea changes brewing, but this latest one’s a real head-turner. MacGregor, those wizards of heavy machinery, have sealed a deal to retrofit 35 ships for Wallenius Wilhelmsen. We’re talking a serious overhaul here, folks, with programmable...

Continue Reading
Springbrook's AI Push: Transforming Local Governance

Updated Category News Views 80

Revolutionizing Government Tech with AI Springbrook Software is positioning itself as a frontrunner in modernizing government tech, unveiling a suite of AI-driven innovations under its Cirrus ERP platform. During their recent conference, Activate 2026, held in Orlando, the commitment to transforming how local governments operate was clear. With new tools like AI Invoicing...

Continue Reading
Aurora Innovation Faces Supply Chain Hurdles & Legal Scrutiny

Updated Category News Views 48

Aurora's Rough Road: Production Delays Unveiled You could almost hear the collective groan from investors when Aurora Innovation dropped the bombshell about its truck production delays. You know, after the cheery faces at the Q3 financial results reveal gave way to a rather grim reality check—driverless trucking ain't rolling out quite as planned thanks to those pesky...

Continue Reading
Kansas City Life's Q3: Earnings Dip, but Growth Ahead

Updated Category News Views 74

Striking a Balance: Kansas City Life's Q3 They say numbers don’t lie, and Kansas City Life Insurance just shared their latest. This quarter, things weren't all smooth sailing, but there's a silver lining. For Q3 2026, net income clocked in at $1.7 million, or $0.18 per share, down from last year’s $2.8 million, or $0.29 per share. Sure, it wasn't all sunshine and...

Continue Reading
Reddit's Stock Plunge Sparks Legal Scrutiny

Updated Category News Views 36

Reddit's Big Gamble: A Risky Shift Investors, grab your coffee, because Reddit (NYSE: RDDT) just gave us a real eyebrow-raiser, and no one's got a clue how deep this rabbit hole goes. They pulled the curtains back and went for a logged-in-only format, and the stock took a nosedive—a good 28% drop, just like that. If you've got a vested interest here, this is your cue to...

Continue Reading
Tampa General Elevates Lokenauth to CFO Amid Growth

Updated Category News Views 36

Charting New Waters at Tampa General Out here in the blue, the tides of healthcare can swell mighty quick. That's where Tampa General Hospital keeps its anchor firm, announcing Lijah Lokenauth's leap to Executive VP and CFO. If you ask me, it's all about keeping the ship steady—this fella's been steering their financial boat through some hefty waves since 2018....

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding Apollo Commercial Real Estate's Dividend Changes

Updated Category News Views 138

Apollo Commercial Real Estate Finance's Recent Dividend Change Apollo Commercial Real Estate Finance, Inc. (NYSE: ARI) has made headlines recently because of a significant shift in its dividend policy. The company has announced a 29% cut in its dividend payout, raising concerns and questions among investors about the reasons behind this move and what it means for the...

Continue Reading
DaVinci Roofscapes Announces 2024 Project Award Winners

Updated Category News Views 411

DaVinci Roofscapes Reveals Award-Winning Projects for 2024 LENEXA, Kan. – DaVinci Roofscapes has proudly announced the winners of the esteemed 2024 Masterpiece Contractor Project of the Year Awards. This annual recognition celebrates outstanding contributions from contractors in the roofing industry across residential and commercial segments. Five remarkable residential...

Continue Reading
Indaptus Therapeutics Expands Clinical Trials for Decoy20

Updated Category News Views 93

Indaptus Therapeutics Reports Exciting Progress in Clinical Trials Indaptus Therapeutics, Inc. (Nasdaq: INDP), a leader in clinical-stage biotechnology, is making significant advancements in developing innovative treatments for cancer and viral infections. Their latest updates highlight important progress in the Decoy20 clinical program, which focuses on increasing...

Continue Reading
New Oriental Plans Shareholders Meeting for Future Engagements

Updated Category News Views 36

New Oriental Sets Stage for Annual General Meeting New Oriental Education & Technology Group Inc. (NYSE: EDU) recently announced that it is preparing for its annual general meeting of shareholders. This event is a great opportunity for shareholders to engage with the company's management team and discuss future directions for the organization. Meeting Details and...

Continue Reading
Understanding the Retirement Struggles of Generation X

Updated Category News Views 194

Generation X, those born between 1965 and 1980, stands on the edge of retirement with a shaky footing. Unlike baby boomers who enjoyed workplace pensions, Gen X had to deal with the decline of such safety nets as they entered their careers. Instead, they’ve mostly relied on 401(k) plans—a shift that hasn’t exactly panned out well for many. The Grim Financial...

Continue Reading